IP Library Granted Patent US 8,636,999
Granted Patent B2
US 8,636,999 · App. 13/378,516 · Granted Jan 28, 2014

Stable plasmid expression vector for bacteria

Inventors: Joe Pogliano (San Diego, CA); Alan Derman (San Diego, CA)
Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,636,999
App. No.
13/378,516
Granted
Jan 28, 2014
Kind
B2
Abstract

The invention provides compositions and methods for stable plasmid maintenance and protein expression in bacteria. Further provided are compositions and methods for promoting competence in bacteria that are otherwise not transformable.

Claims (9)

1. An isolated recombinant plasmid expression vector comprising a polynucleotide encoding a prokaryote-derived actin like protein (ALP) having at least 90% identity to the polypeptide sequence of SEQ ID NO:1, wherein the ALP confers stability on a mobile genetic element when the ALP is expressed in a prokaryotic cell having a mobile genetic element.

2. The vector of claim 1 , wherein the vector encodes an ALP7.

3. The vector according to claim 1 , wherein the ALP comprises: D at the residue corresponding to human beta actin residue 11, G at the residue corresponding to human beta actin residue 13, E or Q at the residue corresponding to human beta actin residue 137, D at the residue corresponding to human beta actin residue 154, and G at the residue corresponding to human beta actin residue 156, when optimally aligned with the polypeptide sequence of human beta actin.

4. The vector of claim 1 , further comprising a polynucleotide encoding a polypeptide sequence having at least 90% identity to SEQ ID NO:411.

5. The vector of claim 1 , further comprising a polynucleotide sequence that encodes a heterologous polypeptide.

6. The vector of claim 5 , wherein the heterologous polypeptide is competence factor K (comK).

7. The vector of claim 6 , further comprising an origin of transfer.

8. An isolated bacteria comprising the plasmid expression vector of claim 1 .

9. The bacteria of claim 8 , wherein the bacteria is a Bacillus or Escherichia strain.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 6, 2014
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032398/0533 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2012
From: POGLIANO, JOE; DERMAN, ALAN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 027712/0092 →
Continuity (2)
Provisional Application 61187592 · Jun 16, 2009
Related Publication 20120184019A1 · Jul 19, 2012